Functional Nucleic Acid-Based Immunomodulation for T Cell-Mediated Cancer Therapy

被引:11
作者
Wu, Hui [1 ]
Lin, Jie [2 ]
Ling, Neng [2 ]
Zhang, Yutong [2 ]
He, Yao [2 ]
Qiu, Liping [1 ,2 ]
Tan, Weihong [1 ,2 ,3 ]
机构
[1] Chinese Acad Sci, Zhejiang Canc Hosp, Hangzhou Inst Med HIM, Hangzhou 310022, Zhejiang, Peoples R China
[2] Hunan Univ, Mol Sci & Biomed Lab MBL, State Key Lab Chemo Biosensing & Chemometr, Coll Chem & Chem Engn,Aptamer Engn Ctr Hunan Prov,, Changsha 410082, Hunan, Peoples R China
[3] Shanghai Jiao Tong Univ, Inst Mol Med IMM, Sch Med, Renji Hosp,Coll Chem & Chem Engn, Shanghai 200240, Peoples R China
基金
中国国家自然科学基金;
关键词
functional nucleic acids; protein regulation; immunomodulation; antigen-presenting cells; T cells; cancer cells; T cell activation; cancer immunotherapy; MESSENGER-RNA VACCINES; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; CIRCULAR RNAS; DNA VACCINES; IMMUNOTHERAPY; APTAMERS; DELIVERY; BINDING; MELANOMA;
D O I
10.1021/acsnano.3c09861
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
T cell-mediated immunity plays a pivotal role in cancer immunotherapy. The anticancer actions of T cells are coordinated by a sequence of biological processes, including the capture and presentation of antigens by antigen-presenting cells (APCs), the activation of T cells by APCs, and the subsequent killing of cancer cells by activated T cells. However, cancer cells have various means to evade immune responses. Meanwhile, these vulnerabilities provide potential targets for cancer treatments. Functional nucleic acids (FNAs) make up a class of synthetic nucleic acids with specific biological functions. With their diverse functionality, good biocompatibility, and high programmability, FNAs have attracted widespread interest in cancer immunotherapy. This Review focuses on recent research progress in employing FNAs as molecular tools for T cell-mediated cancer immunotherapy, including corresponding challenges and prospects.
引用
收藏
页码:119 / 135
页数:17
相关论文
共 181 条
[1]   Evoking picomolar binding in RNA by a single phosphorodithioate linkage [J].
Abeydeera, N. Dinuka ;
Egli, Martin ;
Cox, Nehemiah ;
Mercier, Karen ;
Conde, Jonas Nascimento ;
Pallan, Pradeep S. ;
Mizurini, Daniella M. ;
Sierant, Malgorzata ;
Hibti, Fatima-Ezzahra ;
Hassell, Tom ;
Wang, Tianzhi ;
Liu, Feng-Wu ;
Liu, Hong-Min ;
Martinez, Carlos ;
Sood, Anil K. ;
Lybrand, Terry P. ;
Frydman, Chiraz ;
Monteiro, Robson Q. ;
Gomer, Richard H. ;
Nawrot, Barbara ;
Yang, Xianbin .
NUCLEIC ACIDS RESEARCH, 2016, 44 (17) :8052-8064
[2]   Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86 [J].
Agadjanyan, MG ;
Chattergoon, MA ;
Flolterman, MJ ;
Monzavi-Karbassi, B ;
Kim, JJ ;
Dentchev, T ;
Wilson, D ;
Ayyavoo, V ;
Montaner, LJ ;
Kieber-Emmons, T ;
Sekaly, RP ;
Weiner, DB .
JOURNAL OF IMMUNOLOGY, 2003, 171 (08) :4311-4319
[3]   LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation [J].
Ahn, Green ;
Banik, Steven M. ;
Miller, Caitlyn L. ;
Riley, Nicholas M. ;
Cochran, Jennifer R. ;
Bertozzi, Carolyn R. .
NATURE CHEMICAL BIOLOGY, 2021, 17 (09) :937-946
[4]   A Dual-Targeting Circular Aptamer Strategy Enables the Recognition of Different Leukemia Cells with Enhanced Binding Ability [J].
Ai, Lili ;
Peng, Tianhuan ;
Li, Yingying ;
Kuai, Hailan ;
Sima, Yingyu ;
Su, Minhui ;
Wang, Dan ;
Yang, Qiuxia ;
Wang, Xue-Qiang ;
Tan, Weihong .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 61 (33)
[5]   Targeted Therapy and Immunosuppression in the Tumor Microenvironment [J].
Allegrezza, Michael J. ;
Conejo-Garcia, Jose R. .
TRENDS IN CANCER, 2017, 3 (01) :19-27
[6]   Synthetic cytokine circuits that drive T cells into immune-excluded tumors [J].
Allen, Greg M. ;
Frankel, Nicholas W. ;
Reddy, Nishith R. ;
Bhargava, Hersh K. ;
Yoshida, Maia A. ;
Stark, Sierra R. ;
Purl, Megan ;
Lee, Jungmin ;
Yee, Jacqueline L. ;
Yu, Wei ;
Li, Aileen W. ;
Garcia, K. Christopher ;
El-Samad, Hana ;
Roybal, Kole T. ;
Spitzer, Matthew H. ;
Lim, Wendell A. .
SCIENCE, 2022, 378 (6625) :1186-+
[7]   Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J].
Alvarez-Erviti, Lydia ;
Seow, Yiqi ;
Yin, HaiFang ;
Betts, Corinne ;
Lakhal, Samira ;
Wood, Matthew J. A. .
NATURE BIOTECHNOLOGY, 2011, 29 (04) :341-U179
[8]   Circular RNA vaccine induces potent T cell responses [J].
Amaya, Laura ;
Grigoryan, Lilit ;
Li, Zhijian ;
Lee, Audrey ;
Wender, Paul A. ;
Pulendran, Bali ;
Chang, Howard Y. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (20)
[9]  
Ashkar Ali A., 2002, Current Molecular Medicine (Hilversum), V2, P545, DOI 10.2174/1566524023362159
[10]   Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth [J].
Bai, Chenjun ;
Gao, Shanshan ;
Hu, Sai ;
Liu, Xuemei ;
Li, Hui ;
Dong, Jie ;
Huang, Aixue ;
Zhu, Lingling ;
Zhou, Pingkun ;
Li, Shaohua ;
Shao, Ningsheng .
MOLECULAR THERAPY-ONCOLYTICS, 2020, 17 :9-20